J. McGettigan

发表

Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity.

M. Schnell, C. Wanjalla, Elizabeth J. Faul, 2008, Virology.

Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFkappaB signaling pathway.

M. Schnell, B. Dietzschold, M. Faber, 2008, Vaccine.

Protective Vaccine-Induced CD4+ T Cell-Independent B Cell Responses against Rabies Infection

J. McGettigan, C. Dorfmeier, A. Lytle, 2012, Journal of Virology.

B Cell Infection and Activation by Rabies Virus-Based Vaccines

J. McGettigan, C. Dorfmeier, A. Lytle, 2013, Journal of Virology.

Budding of PPxY-Containing Rhabdoviruses Is Not Dependent on Host Proteins TGS101 and VPS4A

R. N. Harty, M. Schnell, T. Irie, 2004, Journal of Virology.

Rabies virus glycoprotein as a carrier for anthrax protective antigen

R. Pomerantz, M. Schnell, B. Dietzschold, 2006, Virology.

Insect renal tubules constitute a cell-autonomous immune system that protects the organism against bacterial infection.

J. Dow, M. Regulski, G. Gould, 2005, Insect biochemistry and molecular biology.

Conservation of capa peptide-induced nitric oxide signalling in Diptera

S. Davies, P. Cabrero, J. Dow, 2004, Journal of Experimental Biology.

Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.

M. Schnell, Amy B. Papaneri, G. Tan, 2008, Vaccine.

Lymph Node but Not Intradermal Injection Site Macrophages Are Critical for Germinal Center Formation and Antibody Responses to Rabies Vaccination

J. McGettigan, A. Lytle, S. Shen, 2014, Journal of Virology.

Rabies Virus-Based Vectors Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Protein Induce a Strong, Cross-Reactive Cytotoxic T-Lymphocyte Response against Envelope Proteins from Different HIV-1 Isolates

I. M. Belyakov, J. Berzofsky, R. Pomerantz, 2001, Journal of Virology.

Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses

J. McGettigan, J. Plummer, 2019, PLoS neglected tropical diseases.

Overexpression of the Rabies Virus Glycoprotein Results in Enhancement of Apoptosis and Antiviral Immune Response

M. Schnell, B. Dietzschold, R. Pulmanausahakul, 2002, Journal of Virology.

Genetic engineering of live rabies vaccines.

M. Schnell, B. Dietzschold, D. Hooper, 2001, Vaccine.

Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic

R. Pomerantz, M. Schnell, B. Dietzschold, 2003, Journal of Virology.

A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.

M. Schnell, B. Dietzschold, H. D. Foley, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach.

K. Morimoto, M. Schnell, B. Dietzschold, 2000, Journal of neurovirology.

Investigating the Role for IL-21 in Rabies Virus Vaccine-induced Immunity

Evgeni P. Tzvetkov, J. McGettigan, C. Dorfmeier, 2013, PLoS neglected tropical diseases.

A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.

M. Schnell, Amy B. Papaneri, Marie-Luise Faber, 2006, Virology.

Rabies virus nucleoprotein as a carrier for foreign antigens.

H. Koprowski, M. Schnell, G. Tan, 2004, Proceedings of the National Academy of Sciences of the United States of America.

siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.

R. Pomerantz, G. Nunnari, M. Schnell, 2006, Virology.

HIV-1 vaccines: the search continues.

M. Schnell, P. McKenna, J. McGettigan, 2002, Clinics in laboratory medicine.

Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge.

D. Montefiori, A. Lackner, I. Chervoneva, 2009, Vaccine.

The cell biology of rabies virus: using stealth to reach the brain

C. Wirblich, M. Schnell, Amy B. Papaneri, 2010, Nature Reviews Microbiology.

Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.

P. Marx, M. Schnell, Amy B. Papaneri, 2009, The Journal of infectious diseases.

Rhabdoviruses and the Cellular Ubiquitin-Proteasome System: a Budding Interaction

R. N. Harty, J. Huibregtse, M. Whitt, 2001, Journal of Virology.

Experimental rabies vaccines for humans

J. McGettigan, 2010, Expert review of vaccines.

High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector.

M. Schnell, B. Dietzschold, D. Hooper, 2001, Journal of immunological methods.

Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env Expressed from a Single Rhabdovirus-Based Vaccine Vector Genome

J. Orenstein, M. Schnell, P. McKenna, 2003, Journal of Virology.

APRIL:TACI axis is dispensable for the immune response to rabies vaccination

Evgeni P. Tzvetkov, K. Alugupalli, Shannon L. Haley, 2017, Antiviral research.

Recombinant rabies virus as potential live-viral vaccines for HIV-1.

R. Pomerantz, M. Schnell, B. Dietzschold, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Reinvestigating the Role of IgM in Rabies Virus Postexposure Vaccination

Evgeni P. Tzvetkov, J. McGettigan, C. Dorfmeier, 2013, Journal of Virology.

Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis

Evgeni P. Tzvetkov, Shannon L. Haley, J. McGettigan, 2017, Journal of Virology.

A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses.

D. Montefiori, C. Labranche, J. McGettigan, 2015, AIDS research and human retroviruses.

Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs.

M. Figueiredo, M. Schnell, T. Mebatsion, 2014, Vaccine.

ICAM-1-Based Rabies Virus Vaccine Shows Increased Infection and Activation of Primary Murine B Cells In Vitro and Enhanced Antibody Titers In-Vivo

Evgeni P. Tzvetkov, J. McGettigan, C. Dorfmeier, 2014, PloS one.

Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.

L. Eisenlohr, M. Schnell, B. Dietzschold, 2006, Virology.

Expression and Immunogenicity of Human Immunodeficiency Virus Type 1 Gag Expressed by a Replication-Competent Rhabdovirus-Based Vaccine Vector

J. Orenstein, R. Pomerantz, M. Schnell, 2001, Journal of Virology.

Characterization of a Single-Cycle Rabies Virus-Based Vaccine Vector

M. Schnell, P. Flomenberg, Elizabeth J. Faul, 2010, Journal of Virology.

Covalently Linked Human Immunodeficiency Virus Type 1 gp120/gp41 Is Stably Anchored in Rhabdovirus Particles and Exposes Critical Neutralizing Epitopes

R. Pomerantz, M. Schnell, B. Dietzschold, 2003, Journal of Virology.

Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.

J. Dubuisson, R. Pomerantz, M. Schnell, 2002, Virology.

Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses

A. García-Sastre, C. Wirblich, M. Schnell, 2013, PloS one.

Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach.

Jerome H. Kim, M. Schnell, G. Tan, 2005, Virology.

Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.

D. Montefiori, N. Letvin, R. Pomerantz, 2007, The Journal of infectious diseases.

Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases.

R. Pomerantz, M. Schnell, B. Dietzschold, 2003, Current HIV research.

A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.

M. Schnell, Amy B. Papaneri, Marie-Luise Faber, 2006, Virology.

The cell biology of rabies virus: using stealth to reach the brain

C. Wirblich, M. Schnell, Amy B. Papaneri, 2010, Nature Reviews Microbiology.